Overview

Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer

Status:
Completed
Trial end date:
2019-04-12
Target enrollment:
Participant gender:
Summary
This research study is being conducted to assess the safety and feasibility of using a new developed bronchoscopic technology called electronavigational bronchoscopy to treat subjects with solid tumor in peripheral lung, who are inoperable or refused surgery. It will involve 10 sites in USA and Canada. Participation will last 6 months.
Phase:
Phase 1
Details
Lead Sponsor:
Concordia Laboratories Inc.
Treatments:
Dihematoporphyrin Ether
Hematoporphyrin Derivative
Trioxsalen